Source: MarketScreener

Promethera: Promethera� Announces Changes in Management Team

(marketscreener.com) Promethera® Biosciences SA, global innovator in cell-based medicines and liver diseases, today announced a management team update. As of February 21st, Prof. Etienne Sokal, M.D., Ph.D., has stepped back from his operational role as Group CMO and will transition to the position of Chairman of Promethera®'s Scientific & Medical...https://www.marketscreener.com/news/Promethera-Announces-Changes-in-Management-Team--30274658/?utm_medium=RSS&utm_content=20200330

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Etienne Sokal's photo - Chairman of Promethera

Chairman

Etienne Sokal

CEO Approval Rating

90/100

Read more